Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: October 2024 (Report dated October 21, 2024)
Context: The filing reports a significant regulatory milestone regarding the Company's intellectual property portfolio.
Key Financial Metrics
This Form 6-K filing does not contain financial statements, revenue figures, profit data, cash flow information, margins, debt levels, or liquidity metrics. The document serves solely to disclose a corporate event.
Material Changes
Intellectual Property Milestone: On October 21, 2024, Icecure Medical Ltd. received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its next-generation cryoablation system. This represents a material advancement in the Company's patent portfolio and commercialization readiness.
Guidance, Outlook, and Risks
Management Commentary: The filing incorporates by reference the "Forward Looking Statements" section from the accompanying press release (Exhibit 99.1). The text of the Form 6-K itself does not provide specific numerical guidance or detailed risk analysis beyond the standard incorporation of the press release.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for the specific patent number and scope of the allowed claims.
- Verify the timeline for the issuance of the final patent following the Notice of Allowance.
- Assess the competitive landscape for next-generation cryoablation systems to understand the commercial value of this patent.
- Check subsequent filings for any updates on the commercialization strategy for the patented system.